Ivabradine

Symptomatic treatment of chronic stable angina pectoris in coronary artery disease patients with normal sinus rhythm. Ivabradine is indicated:

  • In patients unable to tolerate or with a contra-indication to the use of beta-blockers or
  • In combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose and whose heart rate is > 60 bpm.

There are no products to list in this category.

Continue